Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Non-Squamous Non-Small Cell Lung Cancer × imgatuzumab × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Non-Squamous Non-Small Cell Lung Cancer 1 Colorectal Neoplasms 1

Interventions

Erlotinib Hydrochloride 9 Cisplatin 4 Bevacizumab 4 Paclitaxel 3 Carboplatin 3 onartuzumab 2 Pemetrexed 2 Gemcitabine 2 parsatuzumab 1 imgatuzumab 1 RG-1507 monoclonal antibody 1 Docetaxel 1 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01185847 2016-01-01

A Study of RO5083945 in Combination With Chemotherapy Versus Chemotherapy Alone in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

Hoffmann-La Roche

Phase 2 Completed

Non-Squamous Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡